Does your lab need help collecting pre-clinical oncology xenograft data? Hera BioLabs can help move your research forward with our in vivo xenograft services.
Hera BioLabs is a full-service CRO, offering a full range of in vivo studies in both mouse and rat models. With our state-of-the-art facility, Hera can complete your in vivo efficacy tumor xenograft or PDX model study in your preferred mouse model or our proprietary SRG OncoRat®.
The SRG rat has a double knockout of the Rag2 and Il2rg genes which results in a loss of mature B, T, and NK cells and an immunodeficient phenotype. The SRG rat demonstrates improved tumor growth kinetics and enables the collection of efficacy data in the preferred toxicology and metabolism species and background, the Sprague Dawley rat.
Whether your focus is in vitro screening, gene editing, PDX model establishment, or xenograft drug efficacy studies, our team can help you boost your preclinical oncology research.
Contact us to learn more.